[On the results of treatment and complications during the use of haloperidol in patients with long-term schizophrenia].
D000328:Adult; D001794:Blood Pressure; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002389:Catatonia / Q000188:drug therapy; D002746:Chlorpromazine / Q000009:adverse effects; D003072:Cognition Disorders / Q000139:chemically induced; D006212:Hallucinations / Q000188:drug therapy; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects*; D006309:Hearing; D006801:Humans; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000139:chemically induced; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D012559:Schizophrenia / Q000188:drug therapy*; D012640:Seizures / Q000139:chemically induced; D013564:Sympathetic Nervous System; D014268:Trifluoperazine / Q000009:adverse effects
D014268:Trifluoperazine; D006220:Haloperidol; D002746:Chlorpromazine
O rezul'tatkh lecheniia i oslozhneniiakh pri primenenii galoperidola u bol'nykh s dlitel'nym techeniem shizofrenii.